Catalyst

Slingshot members are tracking this event:

Phase 1 initial safety, PK/PD profile, biomarker analysis from the dose-escalation portion of AB928 + mFOLFOX in Colorectal Cancer Due Q2 2019

Source Link:
https://investors.arcusbio.com/investors/press-releases/press-release-details/2019/Arcus-Biosciences-Announces-First-Quarter-2019-Financial-Results-and-Recent-Corporate-Updates/default.aspx

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
RCUS Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jun 25, 2019
Occurred Source:
https://s22.q4cdn.com/243592055/files/doc_presentations/2019/06/ArcusBiosciencesInvestorCall_06_25_2019.pdf
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Ab928, Mfolfox, Colorectal Cancer
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.